Business Wire - New Data for Cytogen's QUADRAMET® Reported at Annual ASCO Meeting
June 4, 2007 -- Clinical data support feasibility and tolerability of repetitive simultaneous administration of QUADRAMET with docetaxel for prostate cancer patients...
Pharma Marketletter - Cytogen's Quadramet efficacy in tumors.
June 16, 2003 -- New clinical data presented at the American Society of Oncology meeting in Chicago demonstrate synergies of Cytogen's Quadramet (samarium Sm 153...
Business Wire - Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of QUADRAMET® at International Myeloma Workshop
June 28, 2007 -- Novel combination regimen of QUADRAMET with the protease inhibitor, bortezomib, well-tolerated with patients receiving up to four doses; preparations...
Business Wire - New Clinical Data for Cytogen's QUADRAMET and PROSTASCINT to be Reported at Upcoming Major Medical Meetings
March 26, 2007 -- Data to include findings from Phase 1 QUADRAMET combination studies and outcomes data for PROSTASCINT PRINCETON, N.J. -- Cytogen Corporation...
Business Wire - New Clinical Data for PROSTASCINT® and QUADRAMET® in Prostate Cancer Presented at the 2007 Prostate Cancer Symposium
February 24, 2007 -- Multiple abstracts presented at 2007 Prostate Cancer Symposium include two outcomes studies using PROSTASCINT molecular imaging and two studies...
Business Wire - Cytogen Announces Initiation of NCI-Sponsored Phase 2 Clinical Trial of QUADRAMET with Targeted Cancer Vaccine for Hormone-Refractory Prostate Cancer
March 1, 2007 -- PRINCETON, N.J. -- Cytogen Corporation (NASDAQ:CYTO) today announced that the National Cancer Institute (NCI), part of the National Institutes of...
Business Wire - European Association of Nuclear Medicine Journal Article Reports New Data Regarding Administration of QUADRAMET® with Chemotherapy in Hormone Refractory...
January 25, 2007 -- QUADRAMET represents part of a multi-disciplinary medical approach enabling medical oncologists, radiation oncologists and nuclear medicine...
Business Wire - Cytogen Reports First Quarter 2008 Financial Results
May 8, 2008 -- PRINCETON, N.J. -- Cytogen Corporation (NASDAQ: CYTO) today reported its financial results for the first quarter of 2008. Cytogen reported a net...
Business Wire - Cytogen Reports Fourth Quarter and Full Year 2007 Financial Results
March 14, 2008 -- PRINCETON, N.J. -- Cytogen Corporation (NASDAQ: CYTO) today reported its financial results for the fourth quarter and year ended December 31, 2007....
Journal of Nuclear Medicine, The - Petition to Alter NRC Training Regs Denied
December 1, 2007 -- The U.S. Nuclear Regulatory Commission (NRC) announced in the Federal Register on October 24 that it had denied a petition for rulemaking (PRM35-19)...
